777
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Decreased lung hyaluronan in a model of ARDS in the rat: Effect of an inhibitor of leukocyte elastase

, &
Pages 1-9 | Received 30 Jun 2011, Accepted 08 Aug 2011, Published online: 27 Jan 2012

References

  • Quinn DA, Garg HG. Hyaluronan in acute lung injury. In: Vincent JL, editor. Intensive Care Medicine. Annual update 2006. New York: Springer Science + Business Media Inc.; 2006. p. 349–58.
  • Fraser JRE, Laurent TC, Laurent UBG. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med. 1997;242:27–33.
  • Laurent T. Hyaluronan research in Uppsala. Ups J Med Sci. 2007;112:123–42.
  • Boodoo S, Spannhake EW, Powell JD, Horton MR. Differential regulation of hyaluronan-induced IL-8 and IP-10 in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2006;29:L479–86.
  • Nettelbladt O, Tengblad A, Hällgren R. Accumulation of hyaluronan (hyaluronic acid) in lung tissue during experimental alveolitis parallels development of interstitial edema. Am J Physiol. 1989;257:379–84.
  • Ormiston ML, Slaughter GRD, Deng Y, Stewart DJ, Courtman DW. The enzymatic degradation of hyaluronan is associated with disease progression in experimental pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2010;298:L148–57.
  • Hällgren R, Samuelsson T, Laurent TC, Modig J. Accumulation of hyaluronan (hyaluronic acid) in the lung in adult respiratory distress syndrome. Am Rev Respir Dis. 1989;139:682–7.
  • Juul SE, Kinsella MG, Jackson C, Truog WE, Standaert TA, Hodson WA. Changes in hyaluronan deposition during early respiratory distress syndrome in premature monkeys. Pediatr Res. 1994;35:238–43.
  • Johnsson H, Eriksson L, Jonzon A, Laurent TC, Sedin G. Lung hyaluronan and water content in preterm and term rabbit pups exposed to oxygen or air. Pediatr Res. 1998;44:716–22.
  • Juul SE, Kinsella MG, Wight TN, Hodson WA. Alterations in non-human primate (M. nemestrina) lung proteoglycans during normal development and acute hyaline membrane disease. Am J Respir Cell Mol Biol. 1993;8:299–310.
  • Juul SE, Kinsella MG, Truog WE, Gibson RL, Redding GJ. Lung hyaluronan decreases during experimental group B streptococcus (GBS) pneumonia in neonatal piglets. Am J Respir Crit Care Med. 1996;153:1567–70.
  • Rosenbaum D, Peric S, Holecek M, Ward HE. Hyaluronan in radiation-induced lung disease in the rat. Radiation Res. 1997;147:585–91.
  • Kropf J, Globe E, Knoch M, Lammers M, Gressner AM, Lennartz H. The prognostic value of extracellular matrix component concentrations in serum during treatment of a acute respiratory distress syndrome with extracorporeal CO2 removal. Eur J Clin Chem Clin Biochem. 1991;29:805–12.
  • Ahn CM, Sandler H, Glass M, Saldeen T. Effect of a synthetic leukocyte elastase inhibitor on thrombin-induced pulmonary edema in the rat. Exp Lung Res. 1993;19:125–35.
  • Ahn CM, Sandler H, Saldeen T. Beneficial effects of a leukotriene receptor antagonist on thrombin-induced pulmonary edema in the rat. Prostagladins Leukot Essent Fatty Acids. 1995;53:433–8.
  • Moseley R, Waddington RJ, Emberg G. Degradation of glycosaminoglycans by reactive oxygen species derived from stimulated polymorphonuclear leukocytes. Biochim biophys Acta. 1997;1362:221–31.
  • Green SP, Baker MS, Lowther DA. Depolymerization of synovial fluid hyaluronan (HA) by the complete myeloperoxidase (MPO) system may involve the formation of a HA-MPO ionic complex. J Rheumatol. 1990;17:1670–5.
  • Negrini D, Passi A, De Luca G, Miserochi G. Proteoglycan involvement during development of lesional pulmonary edema. Am J Physiol. 1998;274:L203–11.
  • Arfors K-E, Busch C, Jacobson S, Lindquist O, Malmberg P, Rammer L, Pulmonary insufficiency following intravenous infusion of thrombin and AMCA (Tranexamic acid) in the dog. Acta Chir Scand. 1972;138:445–52.
  • Nettelbladt O, Hällgren R. Hyaluronan (hyaluronic acid) in bronchoalveolar lavage fluid during the development of bleomycin-induced alveolitis in the rat. Am Rev Respir Dis. 1989;140:1028–32.
  • Lundberg C, Smedegård G. Regional differences in skin blood flow as measured by radioactive microspheres. Acta Physiol Scand. 1981;111:491–6.
  • Schosser R, Arfors K-E, Messmer K. Mic-II—a program for the determination of cardiac output, arterio-venous shunt and regional blood flow using the radioactive microsphere method. Comput Programs Biomed. 1979;9:19–38.
  • Rodén L, Campbell P, Fraser JRE, Laurent TC, Pertoft H, Thompson JN. Enzymatic pathway of hyaluronan metabolites. CIBA Foundation Symposium. 1989;143:60–86.
  • Fiszer SB, Romman M, Brossard C, Smets P. Hyaluronic acid degrading enzymes in rat alveolar macrophages and in alveolar fluid. Stimulation of enzyme activity after oral treatment with the immunomodulator RU 41740. Biol Cell. 1988;63:355–60.
  • Kobayashi Y, Sakamoto Y, Shibasaki M, Kimura I, Matsuo H. Human alveolar macrophages synthesize endothelins by thrombin. J Immunol. 1997;158:5442–7.
  • Grattendick K, Stuart R, Roberts E, Lincoln J, Lefkowitz SS, Bollen A, Alveolar macrophage activation by myeloperoxidase: a model for exacerbation of lung inflammation. Am J Respir Cell Mol Biol. 2002;26:716–22.
  • Ahn CM, Sandler H, Saldeen T. A leukocyte elastase inhibitor reduces thrombin-induced pulmonary oedema in the rat: mechanisms of action. Pulm Pharmacol Ther. 1998;11:291–9.
  • Drake WT, Lopes NN, Fenton JW, Issekutz AC. Thrombin enhancement of interleukin-1 and tumor necrosis factor-alpha induced polymorphonuclear leukocyte migration. Lab Invest. 1992;67:617–27.
  • Ishibashi M, Nishida T, Murakami H, Shiraishi M, Aritomi T, Yoshida M. The role of interstitial hyaluronan in acute lung injury. Nippon Kyobu Shikkan Gakkai Zasshi. 1995;33S:225–30.
  • Liu YY, Lee CH, Dedaj R, Zhao H, Mrabat H, Sheidlin A, High-molecular-weight hyaluronan—a possible new treatment for sepsis-induced lung injury: a preclinical study in mechanically ventilated rats. Crit Care. 2008;12:R102–13.
  • Berg S, Jansson I, Hesselvik FJ, Laurent TC, Lennquist S, Walther S. Hyaluronan: relationship to hemodynamics and survival in porcine injury and sepsis. Crit Care Med. 1992;20:1315–21.
  • Kawabata K, Hagio T, Matsuoka S. The role of neutrophil elastase in acute lung injury. Eur J Pharmacol. 2002;451:1–10.
  • Tasaka S, Hasegawa N, Ishizaka A. Pharmacology of acute lung injury. Pulm Pharmacol Ther. 2002;15:83–95.
  • Scuri M, Abraham WM. Human blocks human neutrophil elastase (HNE)-induced airway response in sheep. Pulm Pharmacol Ther. 2003;16:335–40.
  • Wang Q, Teder P, Judd NP, Noble PW, Doerschuk CM. CD44 deficiency leads to enhanced neutrophil migration and lung injury in Escherichia coli pneumonia in mice. Am J Pathol. 2002;161:2219–28.
  • Johnson P, Ruffell B. CD44 and its role in inflammation and inflammatory diseases. Inflamm Allergy Drug Targets. 2009;8:208–20.
  • Rasmussen I, Lebel L, Arvidsson D, Haglund U, Laurent TC, Gerdin B. Hepatic extraction of hyaluronic acid in porcine peritonitis. Eur Surg Res. 1995;27:1–10.
  • Ahn CM, Sandler H, Wegener T, Saldeen T. Effect of ibuprofen on thrombin-induced pulmonary edema in the rat. Pulm Pharmacol. 1994;7:393–9.
  • Garrison RN, Ratcliffe DJ, Fry DE. Hepatocellular function and nutrient blood flow in experimental peritonitis. Surgery. 1982;92:713–19.